In previous research, the leaves of the papaya (Carica papaya) have demonstrated potential as an antihypertensive drug. However, research on papaya leaves as an antihypertensive treatment is still rare, especially on its inhibition mechanism of β1 adrenergic receptor and phenylalanine hydrolase receptor. Hence, in silico studies were performed to examine molecularly at the bonding of active substances of papaya leaves with the target proteins. Molecular docking in silico studies were used to examine the free binding energy affinity ∆G and amino acid residue similarity of inhibition mechanism trough β1 adrenergic receptor (code: 7BVQ) and phenylalanine hydrolase receptor (code: 6PAH) to the control carazolol and L-dopa as well as the active substance of the leaves of the papaya. The free bond energy (∆G) and percentage of amino acid residue equation of active compounds of papaya leaves on β1 adrenergic receptor were myricetin (∆G -9.3 kcal/mol, amino acid residue equation 66%), linoleic acid (-6.8 , 66%) and ferulic acid (-7.6, 66%). As for phenylalanine hydrolase receptor the values of carpaine (∆G -8.5 kcal/mol, amino acid residue equation 0%) were obtained. The antihypertensive mechanism of papaya leaves could be mediated by β1 adrenergic receptor because the affinity level of its active substances of its active substances to β1 adrenergic receptor greater than phenylalanine hydrolase receptor.